ACET FY 2017 Earnings — Adicet Bio, Inc. Revenue & Financial Results | Market Cap Arena

ACETAdicet Bio, Inc.

$72M

FY 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$559M+2.1% YoY

Gross Profit

$559M100.0% margin

Operating Income

-$19M-3.4% margin

Net Income

-$34M-6.0% margin

EPS (Diluted)

$-20.00

Cash Flow

Operating Cash Flow

-$12M

Free Cash Flow

-$12M

Stock-Based Comp.

$470,000

Balance Sheet

Total Assets

$55M

Total Liabilities

$6M

Stockholders' Equity

$50M

Cash & Equivalents

$53M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$559M	$547M	+2.1%
Gross Profit	$559M	$135M	+312.4%
Operating Income	-$19M	-$1,000	-1888100.0%
Net Income	-$34M	-$1,000	-3377700.0%